Rabin Medical Center ( Site 5504) — Petah Tikva

Public research footprint of Rabin Medical Center ( Site 5504), compiled from the ClinicalTrials.gov public registry.

1,121

Registered studies

364

Active

171

Recruiting now

464

Completed

132

Stopped or withdrawn

Most-studied conditions

Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD · Diabetic Macular Edema (DME) · Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer · Head and Neck Squamous Cell Carcinoma (HNSCC)

Recently updated registry entries

NCT06065748 — A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a… (Recruiting)
NCT07623161 — A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are… (Recruiting)
NCT06097260 — Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for… (Terminated)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Rabin Medical Center ( Site 5504)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.